Cargando…
Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury
Decreased renal drug clearance is an obvious consequence of acute kidney injury (AKI). However, there is growing evidence to suggest that nonrenal drug clearance is also affected. Data derived from human and animal studies suggest that hepatic drug metabolism and transporter function are components...
Autores principales: | Vilay, A Mary, Churchwell, Mariann D, Mueller, Bruce A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646335/ https://www.ncbi.nlm.nih.gov/pubmed/19040780 http://dx.doi.org/10.1186/cc7093 |
Ejemplares similares
-
Underestimated incidence of kidney disease in nonrenal outpatient
por: Lu, Zeyuan, et al.
Publicado: (2017) -
Mitochondrial Neurogastrointestinal Encephalomyopathy: A Nonrenal Indication for Peritoneal Dialysis
por: Chandra, V. S., et al.
Publicado: (2018) -
Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity
por: Choi, Chan-Bum, et al.
Publicado: (2016) -
Xenobiotic Metabolism: The Effect of Acute Kidney Injury on Non-Renal Drug Clearance and Hepatic Drug Metabolism
por: Dixon, John, et al.
Publicado: (2014) -
Kidney Transplant Outcomes After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: A Single-Center Experience
por: Sood, Puneet, et al.
Publicado: (2016)